AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionKrilogy Financial LLC
Latest Disclosed Ownership15,789 shares
Latest Disclosed Value $ 3,299,779
Krilogy Financial LLC reports 0.97% decrease in ownership of 4AB / AbbVie Inc.

On April 17, 2026 - Krilogy Financial LLC filed a 13F-HR form disclosing ownership of 15,789 shares of AbbVie Inc. (BG:4AB) valued at $3,299,779 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 15,944 shares of AbbVie Inc.. This represents a change in shares of -0.97% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F ABBVIE COM 00287Y109 15,789 -155 -0.97 3,300 -6.25 0.1063
2026-01-27 2025-12-31 13F ABBVIE COM 00287Y109 15,944 -775 -4.64 3,520 -2.90 0.1197
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 16,719 4,919 41.69 3,624 65.48 0.1361
2025-07-09 2025-06-30 13F ABBVIE COM 00287Y109 11,800 1,178 11.09 2,190 -1.57 0.1256
2025-04-16 2025-03-31 13F ABBVIE COM 00287Y109 10,622 -710 -6.27 2,225 10.53 0.1442
2025-01-15 2024-12-31 13F ABBVIE COM 00287Y109 11,332 225 2.03 2,014 -8.21 0.1343
2024-10-15 2024-09-30 13F ABBVIE COM 00287Y109 11,107 -54 -0.48 2,193 14.58 0.1510
2024-07-22 2024-06-30 13F ABBVIE COM 00287Y109 11,161 -111 -0.98 1,914 -6.73 0.1413
2024-04-24 2024-03-31 13F ABBVIE COM 00287Y109 11,272 371 3.40 2,053 21.49 0.1575
2024-01-26 2023-12-31 13F ABBVIE COM 00287Y109 10,901 10,901 1,689 0.1439
2023-07-19 2023-06-30 13F ABBVIE COM 00287Y109 0 -10,038 -100.00 0 -100.00
2023-05-03 2023-03-31 13F ABBVIE COM 00287Y109 10,038 -5,357 -34.80 1,600 -35.73 0.1344
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 15,395 7,164 87.04 2,488 125.16 0.2369
2022-10-06 2022-09-30 13F ABBVIE COM 00287Y109 8,231 374 4.76 1,105 -8.15 0.1319
2022-07-14 2022-06-30 13F ABBVIE COM 00287Y109 7,857 234 3.07 1,203 -2.67 0.1397
2022-04-28 2022-03-31 13F ABBVIE COM 00287Y109 7,623 2,674 54.03 1,236 84.48 0.1263
2022-01-27 2021-12-31 13F ABBVIE COM 00287Y109 4,949 142 2.95 670 29.09 0.0675
2021-10-25 2021-09-30 13F ABBVIE COM 00287Y109 4,807 255 5.60 519 1.17 0.0518
2021-07-20 2021-06-30 13F ABBVIE COM 00287Y109 4,552 -426 -8.56 513 -4.82 0.0512
2021-04-21 2021-03-31 13F ABBVIE COM 00287Y109 4,978 302 6.46 539 7.58 0.0569
2021-02-11 2020-12-31 13F ABBVIE COM 00287Y109 4,676 -167 -3.45 501 18.16 0.0601
2020-11-13 2020-09-30 13F ABBVIE COM 00287Y109 4,843 922 23.51 424 10.13 0.0588
2020-08-06 2020-06-30 13F ABBVIE COM 00287Y109 3,921 423 12.09 385 44.19 0.0590
2020-05-13 2020-03-31 13F ABBVIE COM 00287Y109 3,498 -25 -0.71 267 -14.42 0.0508
2020-02-12 2019-12-31 13F ABBVIE COM 00287Y109 3,523 3,523 312 0.0513
2019-11-13 2019-09-30 13F ABBVIE COM 00287Y109 0 -3,596 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 3,596 309 9.40 262 -1.13 0.0502
2019-05-14 2019-03-31 13F ABBVIE COM 00287Y109 3,287 173 5.56 265 -7.67 0.0561
2019-02-14 2018-12-31 13F ABBVIE COM 00287Y109 3,114 -901 -22.44 287 -24.47 0.0791
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 4,015 -62 -1.52 380 0.53 0.0862
2018-08-15 2018-06-30 13F ABBVIE COM 00287Y109 4,077 1,062 35.22 378 32.63 0.0954
2018-05-15 2018-03-31 13F ABBVIE COM 00287Y109 3,015 -208 -6.45 285 -8.65 0.0680
2018-02-14 2017-12-31 13F ABBVIE COM 00287Y109 3,223 -183 -5.37 312 2.97 0.0753
2017-11-15 2017-09-30 13F ABBVIE COM 00287Y109 3,406 339 11.05 303 36.49 0.0773
2017-08-15 2017-06-30 13F ABBVIE COM 00287Y109 3,067 -1,263 -29.17 222 -18.08 0.0620
2017-05-16 2017-03-31 13F ABBVIE COM 00287Y109 4,330 0 0.00 271 0.00 0.0842
2017-02-15 2016-12-31 13F ABBVIE COM 00287Y109 4,330 223 5.43 271 4.63 0.0842
2016-11-15 2016-09-30 13F ABBVIE COM 00287Y109 4,107 200 5.12 259 7.02 0.0823
2016-08-16 2016-06-30 13F ABBVIE COM 00287Y109 3,907 -228 -5.51 242 2.54 0.0841
2016-05-13 2016-03-31 13F ABBVIE COM 00287Y109 4,135 2,311 126.70 236 118.52 0.0971
2016-02-29 2015-12-31 13F * ABBVIE COM 00287Y109 1,824 500 37.76 108 50.00 0.1003
2015-11-25 2015-09-30 13F ABBVIE COM 00287Y109 1,324 1,324 72 0.0343
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.